-
Recent Posts
Categories
- Anesthesiology
- Avandia
- Cardiology
- Clinics
- Consumer Products
- Emergency Rooms
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Hospitals
- Infectious Disease
- Internal Medicine
- Laboratory
- multiple sclerosis (MS)
- Neurology
- OBGYN
- Oncology
- Ophthalmology
- Pain Management
- Patients
- Pediatrics
- Pharmacy
- Psychiatry
- Radiology
- Rheumatology
- Risk Manager
- Uncategorized
Tag Archives: Recall
Brilliant Blue G Recall
Brilliant Blue G: Recall of Unapproved Drug – Ongoing Investigation of Fungal Endophthalmitis Cases AUDIENCE: Ophthalmology, Risk Manager ISSUE: FDA has received reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G (BBG) during eye surgeries. Clinicians … Continue reading
Posted in FDA 2012, FDA Recall, Ophthalmology, Risk Manager
Tagged Brilliant Blue G Recall, drug risks, eye infections, eye surgery, FDA recall, Franck’s Compounding Lab, fungal endophthalmitis, Fungal Endophthalmitis Cases, Ocala Florida, Ongoing Investigation, Ophthalmology, Recall, Unapproved Drug
Comments Off
Acclarent Inspira AIR Balloon Dilation System Class 1 Recall
Acclarent Inspira AIR Balloon Dilation System: Class 1 Recall – Potential For Balloon To Not Deflate Or To Deflate To Slowly AUDIENCE: Emergency Medicine, Risk Managers ISSUE: Acclarent received four reports of incidents, one resulting in patient injury, in which … Continue reading
Gerber Good Start Gentle Powdered Infant Formula Recall
Gerber Good Start Gentle Powdered Infant Formula: Recall – Off-Odor AUDIENCE: Consumers, Pediatrics ISSUE: Gerber notified the public that it recalled one lot of Gerber Good Start Gentle Powdered Infant Formula, 23.2 ounce plastic package, because the affected product might … Continue reading
Posted in Consumer Products, FDA 2012, FDA Recall, Pediatrics
Tagged Consumer Products, drug, FDA recall, Gentle Powdered, Gerber, Gerber Good Start Gentle Powdered Infant Formula Recall, Good Start, Infant Formula, Pediatrics, Recall
Comments Off
Automated External Defibrillators AEDs Class I Recall
Cardiac Science Powerheart, CardioVive, CardioLife; GE Responder and Responder Pro; and Nihon-Kohden Automated External Defibrillators (AEDs): Class I Recall – Defective Component Affected Models include: Powerheart 9300A, 9300E, 9300P, 9390A, and 9390E CardioVive 92532, 92533 CardioLife 9200G and 9231 GE … Continue reading
Posted in Cardiology, Emergency Rooms, FDA 2012, FDA Recall, Risk Manager
Tagged AEDs, Automated External Defibrillators, Cardiac Science Powerheart, CardioLife, Cardiology, CardioVive, Class 1 Recall, Class I Recall, Defective Component, Emergency Medicine, FDA recall, GE Responder, Nihon-Kohden, Recall, Responder Pro
Comments Off
Flight Medical V240040029 Cable for Newport HT50 Ventilator Class I Recall
Flight Medical V24-00400-29 Cable for Newport HT50 Ventilator: Class I Recall – Cable May Cause an Electrical Shortage That can Cause Ventilators to Shutdown Unexpectedly ISSUE: The recalled cable may cause an electrical shortage that can cause Newport HT50 … Continue reading
Norgestimate and Ethinyl Estradiol Tablets Recall
Norgestimate and Ethinyl Estradiol Tablets: Recall – Packaging Error, Potential for Incorrect Dosing Regimen AUDIENCE: OB/GYN, Pharmacy, Patient ISSUE: Glenmark Generics Inc. issued a nationwide, consumer-level recall of seven (7) lots of Norgestimate and Ethinyl Estradiol Tablets USP (0.18 mg/0.035 … Continue reading
Posted in OBGYN, Pharmacy
Tagged Birth Control Pills, Dietary Supplements, drug risks, Ethinyl Estradiol Tablets, Family Practice, FDA recall, Norgestimate, Norgestimate and Ethinyl Estradiol Tablets Recall, OBGYN, Oral Contraceptives, Packaging Error, Patient, Pharmacy, Recall
Comments Off
Cytarabine for Injection 1 gm vial Bedford Labs Recall
Cytarabine for Injection, 1 gm/vial [Bedford Labs]: Recall: Risk of Lack of Sterility ISSUE: Bedford Laboratories announced a nationwide recall of three lots of cytarabine for injection—2066986, 2111675, and 2131148—because vials have a potential risk of a lack of sterility. The risk … Continue reading
Posted in Clinics, Emergency Rooms, Family Practice, FDA 2012, FDA Recall
Tagged 1 gm vial, Bedford Labs, Clinics, Cytarabine for Injection, Cytarabine for Injection 1 gm vial Bedford Labs Recall, drug risks, Emergency Rooms, Family Practice, FDA recall, Hospitals, Pharmacy, physician offices, Recall
Comments Off